Biotechnology Innovation Organization (BIO) comments on the FDA docket, Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction. BIO also believes that risks associated with opioid therapies can be surmounted through further…
Letters, Testimony & Comments | April 6, 2021 | Human Health, Drug Development Process, Genetic, Cell Therapy, Policy & Regulatory, FDA Guidance, FDA Regulations
On Tuesday, April 6th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s January 2021 draft industry guidance on “Human Gene Therapy for Neurodegenerative Diseases.” In its comments, BIO stated that while the guidance covers many critical development issues for gene therapies,…
Dear Secretary Buttigieg, National Climate Advisor McCarthy, and Director Deese:
The undersigned organizations, representing aviation industry stakeholders including passenger and cargo carriers, business and general aviation, aircraft and engine manufacturers, airports, pilots, flight attendants…
On behalf of the Biotechnology Innovation Organization (BIO), the global industry organization representing the biotechnology industry, I want to express support for House Bill 1091, which recently passed the Washington Legislature. BIO member companies are at the forefront of developing solutions…
The Biotechnology Innovation Organization (BIO) is pleased to respond to the U.S. Department of Agriculture’s (USDA) Request for Comments: Executive Order on Tackling the Climate Crisis at Home and Abroad as USDA develops a Climate-Smart Agriculture and Forestry Approach.
BIO applauds the…
As the federal government begins to implement IRA, BIO urges the administration to take additional steps to foster the development and deployment of pioneering technologies that will further reduce greenhouse gas emissions in manufacturing, transportation, and agricultural supply chains to build a…
Good Day BIO Newsletter Archive | February 5, 2024
BIO warns USTR of global threats to U.S. IP (including WTO waivers), while several new reports highlight the importance of biotech to sustainable farm productivity. (621 words, 3 minutes, 6 seconds)
This webinar will help BIO 2024 attendees/exhibitors better prepare for their onsite experience at the event. We will provide important and practical onsite information, as well as provide further instruction on how to more effectively use advanced features of the BIO One-on-One Partnering™ system…
The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Position yourself for success at this year's event, June 3-6, in San Diego! BIO is where business and breakthroughs…
Join BIO staff as they walk exhibitors through the tools needed to plan for BIO International 2024!
The goal of this webinar is to provide our exhibitors with the resources to have an impactful presence in San Diego as well as provide additional details.
The following topics will be discussed:
…